{{Rsnum
|rsid=50872
|Gene=ERCC2
|Chromosome=19
|position=45359191
|Orientation=plus
|GMAF=0.208
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ERCC2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.9 | 45.1 | 8.0
| HCB | 65.7 | 30.7 | 3.6
| JPT | 65.5 | 31.0 | 3.5
| YRI | 72.8 | 26.5 | 0.7
| ASW | 71.9 | 24.6 | 3.5
| CHB | 65.7 | 30.7 | 3.6
| CHD | 62.4 | 31.2 | 6.4
| GIH | 66.3 | 29.7 | 4.0
| LWK | 61.5 | 31.2 | 7.3
| MEX | 65.5 | 34.5 | 0.0
| MKK | 50.0 | 39.1 | 10.9
| TSI | 56.9 | 37.3 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21751184
|Title=SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population
}}

{{PMID|20128036|OA=1
}} DNA polymorphism and risk of esophageal squamous cell carcinoma in a population of North Xinjiang, China.

{{PMID Auto
|PMID=22608006
|Title=Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}